{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:16:36Z","timestamp":1790982996031,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,15]]},"DOI":"10.7759\/cureus.112729","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:20:28Z","timestamp":1784132428000},"source":"Crossref","is-referenced-by-count":1,"title":["Tirofiban-Associated Thrombocytopenia: A Case Report"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayatullah","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Majwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Marashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talib","family":"Majwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.04.031","article-title":"Impact of glycoprotein IIb\/IIIa inhibition in contemporary percutaneous coronary intervention for acute coronary syndromes: insights from the National Cardiovascular Data Registry","volume":"8","author":"Safley DM","year":"2015","unstructured":"Safley DM, Venkitachalam L, Kennedy KF, Cohen DJ. Impact of glycoprotein IIb\/IIIa inhibition in contemporary percutaneous coronary intervention for acute coronary syndromes: insights from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2015, 8:1574-82. 10.1016\/j.jcin.2015.04.031","journal-title":"JACC Cardiovasc Interv"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000127867.41621.85","article-title":"Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting","volume":"109","author":"Merlini PA","year":"2004","unstructured":"Merlini PA, Rossi M, Menozzi A, et al.. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting. Circulation. 2004, 109:2203-6. 10.1161\/01.CIR.0000127867.41621.85","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072212","article-title":"Pathophysiology and diagnosis of drug-induced immune thrombocytopenia","volume":"9","author":"Vayne C","year":"2020","unstructured":"Vayne C, Gu\u00e9ry EA, Rollin J, Baglo T, Petermann R, Gruel Y. Pathophysiology and diagnosis of drug-induced immune thrombocytopenia. J Clin Med. 2020, 9:10.3390\/jcm9072212","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V100.6.2071","article-title":"Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb\/IIIa","volume":"100","author":"Bougie DW","year":"2002","unstructured":"Bougie DW, Wilker PR, Wuitschick ED, et al.. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb\/IIIa. Blood. 2002, 100:2071-6.","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12052","article-title":"A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia","volume":"11","author":"Arnold DM","year":"2013","unstructured":"Arnold DM, Kukaswadia S, Nazi I, et al.. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost. 2013, 11:169-76. 10.1111\/jth.12052","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.117.005635","article-title":"Incidence, predictors, and outcomes of acquired thrombocytopenia after percutaneous coronary intervention: a pooled, patient-level analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)","volume":"11","author":"Groves EM","year":"2018","unstructured":"Groves EM, Bhatt DL, Steg PG, et al.. Incidence, predictors, and outcomes of acquired thrombocytopenia after percutaneous coronary intervention: a pooled, patient-level analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition). Circ Cardiovasc Interv. 2018, 11:e005635. 10.1161\/CIRCINTERVENTIONS.117.005635","journal-title":"Circ Cardiovasc Interv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S292567","article-title":"Aspirin \u201callergy\u201d-induced thrombocytopenia: a case report","volume":"14","author":"Fu W","year":"2021","unstructured":"Fu W, Xu S, Dong X, Xie Q, Gao Y. Aspirin \u201callergy\u201d-induced thrombocytopenia: a case report. J Asthma Allergy. 2021, 14:201-5. 10.2147\/JAA.S292567","journal-title":"J Asthma Allergy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/joah.joah_99_23","article-title":"Absolute thrombocytopenia with ticagrelor","volume":"15","author":"Hafiz A","year":"2024","unstructured":"Hafiz A, Aljuhani O, Al Sulaiman K, Ashram W, Radhwi O. Absolute thrombocytopenia with ticagrelor. J Appl Hematol. 2024, 15:82-5. 10.4103\/joah.joah_99_23","journal-title":"J Appl Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1328894","article-title":"Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)","volume":"38","author":"Jacob S","year":"2012","unstructured":"Jacob S, Dunn BL, Qureshi ZP, et al.. Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012, 38:845-53. 10.1055\/s-0032-1328894","journal-title":"Semin Thromb Hemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)00688-4","article-title":"Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy","volume":"36","author":"Sane DC","year":"2000","unstructured":"Sane DC, Damaraju LV, Topol EJ, et al.. Occurrence and clinical significance of pseudothrombocytopenia during abciximab therapy. J Am Coll Cardiol. 2000, 36:75-83. 10.1016\/s0735-1097(00)00688-4","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241030-00003","article-title":"Clinical pharmacokinetics of tirofiban, a nonpeptide glycoprotein IIb\/IIIa receptor antagonist: comparison with the monoclonal antibody abciximab","volume":"41","author":"Kondo K","year":"2002","unstructured":"Kondo K, Umemura K. Clinical pharmacokinetics of tirofiban, a nonpeptide glycoprotein IIb\/IIIa receptor antagonist: comparison with the monoclonal antibody abciximab. Clin Pharmacokinet. 2002, 41:187-95. 10.2165\/00003088-200241030-00003","journal-title":"Clin Pharmacokinet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1130552","article-title":"Case report: reuse of tirofiban leads to very severe thrombocytopenia","volume":"10","author":"Li Y","year":"2023","unstructured":"Li Y, Qiu J, Gao Y, Li G. Case report: reuse of tirofiban leads to very severe thrombocytopenia. Front Cardiovasc Med. 2023, 10:1130552. 10.3389\/fcvm.2023.1130552","journal-title":"Front Cardiovasc Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01829.x","article-title":"Thrombocytopenia associated with the use of GPIIb\/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb\/IIIa inhibitors","volume":"4","author":"Aster RH","year":"2006","unstructured":"Aster RH, Curtis BR, Bougie DW, Dunkley S, Greinacher A, Warkentin TE, Chong BH. Thrombocytopenia associated with the use of GPIIb\/IIIa inhibitors: position paper of the ISTH working group on thrombocytopenia and GPIIb\/IIIa inhibitors. J Thromb Haemost. 2006, 4:678-9. 10.1111\/j.1538-7836.2006.01829.x","journal-title":"J Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-006-0459-7","article-title":"Glycoprotein IIb\/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment","volume":"96","author":"Said SM","year":"2007","unstructured":"Said SM, Hahn J, Schleyer E, M\u00fcller M, Fiedler GM, Buerke M, Prondzinsky R. Glycoprotein IIb\/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment. Clin Res Cardiol. 2007, 96:61-9. 10.1007\/s00392-006-0459-7","journal-title":"Clin Res Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1522-726x(199909)48:1<71::aid-ccd14>3.0.co;2-2","article-title":"Possible anaphylactic reaction to abciximab","volume":"48","author":"Guzzo JA","year":"1999","unstructured":"Guzzo JA, Nichols TC. Possible anaphylactic reaction to abciximab. Catheter Cardiovasc Interv. 1999, 48:71-3. 10.1002\/(sici)1522-726x(199909)48:1&lt;71::aid-ccd14&gt;3.0.co;2-2","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt LJ","year":"2017","unstructured":"Estcourt LJ, Birchall J, Allard S, et al.. Guidelines for the use of platelet transfusions. Br J Haematol. 2017, 176:365-94. 10.1111\/bjh.14423","journal-title":"Br J Haematol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/000331970505600319","article-title":"Profound thrombocytopenia associated with tirofiban: case report and review of literature","volume":"56","author":"Patel S","year":"2005","unstructured":"Patel S, Patel M, Din I, Reddy CV, Kassotis J. Profound thrombocytopenia associated with tirofiban: case report and review of literature. Angiology. 2005, 56:351-5. 10.1177\/000331970505600319","journal-title":"Angiology"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020402","article-title":"Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention","volume":"99","author":"Wang H","year":"2020","unstructured":"Wang H, Feng M. Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention. Medicine (Baltimore). 2020, 99:e20402. 10.1097\/MD.0000000000020402","journal-title":"Medicine (Baltimore)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01456","article-title":"A simple clinical pre-procedure risk model for predicting thrombocytopenia associated with periprocedural use of tirofiban in patients undergoing percutaneous coronary intervention","volume":"9","author":"Yi YH","year":"2018","unstructured":"Yi YH, Yin WJ, Gu ZC, et al.. A simple clinical pre-procedure risk model for predicting thrombocytopenia associated with periprocedural use of tirofiban in patients undergoing percutaneous coronary intervention. Front Pharmacol. 2018, 9:1456. 10.3389\/fphar.2018.01456","journal-title":"Front Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/411202-tirofiban-associated-thrombocytopenia-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:20:29Z","timestamp":1784132429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/411202-tirofiban-associated-thrombocytopenia-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.112729","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,15]]}}}